P. Corris (Newcastle-Upon-Tyne, United Kingdom), M. Humbert (Le Kremlin-Bicêtre, France)
The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
S. Zhang, Z. Zhai, Y. Yang, T. Kuang, C. Wang (Beijing, China)
|   |
Measurement of gas transfer components using nitric oxide in post pulmonary endartectomy (PEA) chronic thromboembolic hypertension (CTEPH) patients
L. Harlow, K. Oates, R. MacKenzie-Ross, J. Pepka-Zaba (Cambridge, United Kingdom)
| |
Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension
L. Guo, J. Cai, L. Wang, J. Li, J. Liu, Y. Yang, B. Pang, Z. Zhai, Y. Liu, S. Gu, C. Wang, J. Wang (Beijing, China)
| |
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
A. Ferré, B. Planquette, A. Vial, A. Roux, J. Emmerich, G. Meyer, O. Sanchez (Paris, France)
| |
Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
S. Günther, O. Mercier, X. Jaïs, D. Montani, S. Maitre, J.F. Paul, V. de Montpréville, E. Fadel, M. Humbert, G. Simonneau, P. Dartevelle, P. Dorfmüller (Clamart, Le Plessis Robinson, Kremlin-Bicêtre, France)
| |
Inventive protocols of CT pulmonary angiography (CTPA) avoid artifacts in right pulmonary artery (rPA), improving detectability of pulmonary embolism (PE)
M. Ikura, H. Ikura, H. Abe, S. Watanabe, S. Kimoto, Y. Kawawa (Imabari, Tokyo, Japan)
| |
Sleep-disordered breathing in acute pulmonary embolism: A dangerous comorbidity?
T.M. Berghaus, C. Faul, F. Unterer, W. von Scheidt, M. Schwaiblmair (Augsburg, Germany)
| |
Red cell distribution width (RDW): A new predictor for chronic thromboembolic pulmonary hypertension
Y. Abul, S. Ozsu, A. Korkmaz, Y. Bulbul, T. Ozlu (Trabzon, Rize, Turkey)
| |
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
S. Zhang, Z. Zhai, Y. Yang, T. Kuang, W. Xie, C. Wang (Beijing, China)
| |
Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children
M. Levy, D. Bonnet, L. Mauge, C. d‘Audigier, D. Celermajer, P. Gaussem, D. Smadja (Paris, France)
| |
Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension
T. Sato, I. Tsujino, H. Ohira, N. Oyama-Manabe, M. Nishimura (Sapporo, Japan)
| |
Atrial flutter and fibrillation in patients with chronic pulmonary hypertension
K. Olsson, N. Nickel, J. Tongers, M. Hoeper (Hanover, Germany)
| |
The imPAHct of diagnosis delay in pulmonary arterial hypertension
I. Armstrong, C. Harries, J. Yorke (Sheffield, London, United Kingdom)
| |
Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
M. Halank, F. Einsle, S. Christoph, H. Bremer, R. Ewert, H. Wilkens, J. Meyer, H.J. Seyfarth, M. Kolditz, G. Wieder, G. Hoeffken, V. Koellner (Dresden, Donaueschingen, Greifswald, Homburg/Saar, Munich, Leipzig, Germany)
| |
Prognostic risk factors of disease worsening in patients with functional class II pulmonary arterial hypertension
G. Simonneau, N. Galiè, M.M. Hoeper, A. Kusic-Pajic, J.C. Lemarié, L.J. Rubin (Le Kremlin Bicêtre, Paris, France; Bologna, Italy; Hanover, Germany; Allschwil, Switzerland; San Diego, United States Of America)
| |
Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients
E. Parsley, H. Masamune, W. Hoye, N. Kadrichu, A. Hussaini, L. Rubin, M. Gladwin, M. Mancini (San Diego, Baltimore, , San Carlos, United States Of America)
| |
Potential pharmacological interactions between oral pulmonary arterial hypertension (PAH) therapies and new oral anticoagulants
L. Bertoletti, X. Delavenne, D. Montani, J.C. Lega, M. Humbert, P. Mismetti (Saint-Etienne, Kremlin-Bicêtre, Clamart, France)
| |
To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients
S. Kumar, P.K. Sharma, M.K. Sharma, A. Kumar, S.K. Sarin (New Delhi, India)
| |